FDA NDC Directory · JSON-LD · Markdown

Gazyva

NDC 50242-070 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic nameobinutuzumab
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA125486
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsOBINUTUZUMAB (1000 mg/40mL)
Marketing started20131101
Package count2

External sources

Source: openFDA. Public-domain (CC0).